info@seagull-health.com
SeagullHealth
语言:
search
new
How much is a box of Quizartinib?
500
Article source: Seagull Pharmacy
Jul 15, 2025

Quizartinib is a drug for the treatment of specific leukemia, which has attracted much attention from the medical community and patients. Its price varies depending on the manufacturer, specifications and regional differences. This article will introduce the price, usage, dosage and precautions of Quizartinib in detail to help patients better understand and use this drug.

How much is a box of Quizartinib?

The price of Quizartinib varies depending on various factors, the most critical of which is the manufacturer and specifications of the drug.

Price of Indian version of Quizartinib

According to data, the price of the Indian version of Quizartinib 17.7mg specification may be more affordable than that of other countries or regions, which has attracted the attention of many patients.

Reasons for price differences

The reasons for the price differences of Quizartinib mainly include production costs, R&D investment, market demand and regional policies. Different manufacturers may use different processes and raw materials in the production process, resulting in different costs. Market demand and regional policies are also important factors affecting drug prices.

The price of Quizartinib varies depending on many factors. When purchasing, patients need to combine their own economic conditions, medication needs and doctor's advice to choose the drug specifications and manufacturers that suit them.

Dosage and Administration of Quizartinib

The dosage and administration of Quizartinib is very important for drug efficacy and reducing adverse reactions.

Recommended Usage

Quizartinib is usually used in adult patients, and the recommended dosage is oral. The initial dose is 26.5 mg once a day for two weeks. The dose is then increased to 53 mg once a day. The doctor will adjust the dose according to the patient's specific situation and response. The cycle needs to be determined according to the patient's specific situation.

Usage in special circumstances

In some special circumstances, such as patients with liver and kidney dysfunction, elderly patients or children, the dosage and administration of Quizartinib may need to be adjusted appropriately. These patients should strictly follow the doctor's advice when using Quizartinib.

The dosage and administration of Quizartinib should strictly follow the doctor's advice. Patients should pay close attention to their own reactions during use and provide feedback to the doctor in a timely manner.

Precautions for Quizartinib

When using Quizartinib, patients should pay attention to the following matters.

QT interval prolongation

Quizartinib may cause QT interval prolongation and increase the risk of heart problems. Before using Quizartinib, patients need to undergo an electrocardiogram (ECG) and monitor the ECG regularly during medication. Also pay attention to electrolyte levels, such as potassium and magnesium, and perform electrolyte correction if necessary.

Bone marrow suppression and bleeding

Quizartinib may cause adverse reactions such as bone marrow suppression and bleeding. Before using Quizartinib, patients need to undergo a routine blood test and pay close attention to blood cell counts during medication. If signs of bone marrow suppression or bleeding occur, the drug should be stopped immediately and medical attention should be sought.

When using Quizartinib, patients need to pay close attention to their own reactions and follow the doctor's advice to help the treatment effect.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Quizartinib(VANFLYTA)
Quizartinib(VANFLYTA)
VANFLYTA is indicated for adult patients with newly diagnosed Acute Myeloid...
WeChat Scan
Free Inquiry
Recommended Articles
What are the adverse reactions of rivastigmine transdermal patch?
Rivastigmine transdermal patch is a drug used to treat Alzheimer's disease and Parkinson's disease dementia. It has significant efficacy, but it also has certain adverse reactions. It is very ...
What are the side effects of rivastigmine?
Rivastigmine is a drug used to treat Alzheimer's and Parkinson's dementia. It has significant efficacy, but it is also accompanied by a series of possible side effects. One of the common side ...
What is Rivastigmine?
Rivastigmine, developed by Novartis, is an innovative drug for the treatment of Alzheimer's and Parkinson's dementia. Rivastigmine is administered in the form of a transdermal patch, providing...
What is Rivastigmine transdermal patch?
Rivastigmine transdermal patch is an innovative form of drug designed to treat specific types of dementia. Rivastigmine transdermal patch provides continuous drug treatment in the form of a transderma...
How to buy Quizartinib
Quizartinib is a therapeutic drug for specific leukemia. Its purchase channels, specifications, properties and indications are the focus of patients and their families. This article will focus on thes...
Indications of Quizartinib
Quizartinib is a targeted therapy for acute myeloid leukemia caused by specific gene mutations. It is mainly used to treat relapsed or refractory FLT3-ITD mutation-positive AML and works by inhib...
Quizartinib instructions, medical insurance, price, efficacy, side effects
Quizartinib is a drug for the treatment of specific leukemias, which has attracted widespread attention in the international medical field. This article will conduct an in-depth discussion on the...
How to use Quizartinib
Quizartinib is a therapeutic drug for patients with specific acute myeloid leukemia (AML). This article aims to introduce in detail the use of Quizartinib, drug interactions and precautions for s...
Related Articles
Side Effects of Quizartinib
Quizartinib is an oral kinase inhibitor primarily indicated for the treatment of newly diagnosed FLT3-ITD-positive acute myeloid leukemia (AML). As a targeted therapy, it offers therapeutic efficacy a...
What are the precautions for taking Quizartinib?
Quizartinib is a selective FLT3 kinase inhibitor indicated for the treatment of adult patients with newly diagnosed FLT3-ITD positive acute myeloid leukemia (AML). When used in combination with standa...
Dosage and Administration of Quizartinib
Quizartinib is a kinase inhibitor targeting the FLT3 receptor, which was first approved in the United States in 2023. In combination with standard induction therapy using cytarabine and anthracyclines...
What are the Indications of Quizartinib?
Quizartinib is an innovative kinase inhibitor that received its first approval in the United States in 2023.What are the Indications of Quizartinib?Primary Therapeutic AreaQuizartinib is a kinase inhi...
What Are the Purchase Channels for Quizartinib?
Quizartinib is a kinase inhibitor indicated for adult patients with newly diagnosed acute myeloid leukemia (AML) who have been confirmed to carry the FLT3 internal tandem duplication (FLT3-ITD) mutati...
Precautions when taking Quizartinib
Quizartinib (Vanflyta) is indicated for the treatment of newly diagnosed adult patients with acute myeloid disease (AML) who are positive for FLT3 internal tandem duplication (ITD) as detected by...
Side effects of Quizartinib
Quizartinib is a targeted therapy for FLT3 mutation-positive acute myeloid leukemia, which has shown certain efficacy in clinical applications. Its use is also accompanied by a series of side eff...
How effective is Quizartinib(Vanflyta)?
Quizartinib (Vanflyta) is a targeted therapy for FLT3 mutation-positive acute myeloid leukemia (AML). It has excellent therapeutic effects and is highly concerned by patients. The following is a ...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved